Navigation Links
Shire Continues to Deliver Excellent Growth From Core Products
Date:10/30/2009

osts 2.0 - - (2.0) Integration and acquisition costs 6.2 - (6.2) - Depreciation - - - - Total operating expenses 575.2 (34.8) (6.8) (0.2) Operating income 91.8 34.8 6.8 0.2 Interest income 0.2 - - - Interest expense (9.4) - - - Other income, net 7.0 - - - Total other expense, net (2.2) - - - Income from continuing operations before income taxes and equity in earnings of equity method investees 89.6 34.8 6.8 0.2 Income taxes (30.6) (9.9) (1.8) (0.5) Equity in earnings of equity method investees, net of tax 0.6 - - - Net income attributable to Shire plc 59.6 24.9 5.0 (0.3) Numerator for diluted EPS 59.6 24.9 5.0 (0.3) Weighted average number of shares (millions) - diluted 548.3 - - - Diluted earnings per ADS 32.7c 13.5c 2.7c - Non GAAP Reclassify September 3 months to, depreciation 30, 2009 (d) $M $M Total revenues - 667.0 Costs and expenses: Cost of product sales (0.8) 99.0 Research and development (3.6) 144.2 Sel
'/>"/>
SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014  Sprout Pharmaceuticals today announced positive preliminary results from ... with flibanserin up to 200 mg at bedtime had no ... the 20 th Annual Fall Scientific Meeting of the ... in Miami . The Phase ... Response Letter and the Formal Dispute Resolution that was filed ...
(Date:11/22/2014)... 21 de noviembre de 2014  BioClinica®, Inc., ... externalizados y tecnologías eClinical, ha indicado un aumento ... inteligente, para el seguimiento basado en el riesgo ... el concepto del seguimiento basado en el riesgo ... visitas de seguimiento o cambio de los métodos ...
(Date:11/22/2014)... , Nov. 21, 2014 MEDITE Group acquired ... nine months and the 3 rd quarter sales ended ... income was $448,000 for the nine months ended September 2014 ... "Even though our 3 rd quarter is usually a ... extends from July into September for many countries worldwide, we ...
Breaking Medicine Technology:Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3
... ("Volition" or the "Company"), a life sciences company focused on ... shareholders from Cameron Reynolds, CEO: Dear Shareholders, ... growing and the fact that we have been reaching our ... and look forward to future goals that will continue to ...
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ... and infectious diseases, announced today that VGX-3100, its investigational ... by human papillomavirus, was highlighted by Fierce Vaccines ... (see VGX-3100 – Cervical cancer). Inovio is currently ...
Cached Medicine Technology:VolitionRX Limited Issues Update Letter to Shareholders 2VolitionRX Limited Issues Update Letter to Shareholders 3VolitionRX Limited Issues Update Letter to Shareholders 4VolitionRX Limited Issues Update Letter to Shareholders 5Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling 2Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling 3Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling 4Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling 5Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling 6
(Date:11/23/2014)... 2014 iFitDress.com, a well-known wedding dress manufacturer, ... gowns . They are now offered at deeply discounted ... last from now to Dec. 15. The main purpose of ... the company’s high quality items are ideal options for ladies ... sum of money. All its new mint cocktail dresses are ...
(Date:11/23/2014)... TX (PRWEB) November 23, 2014 ... Devices Market 2006 to 2020 - Asia-Pacific” provides ... energy devices market segments: minimally invasive body contouring ... devices. The analysis includes market size data by ... for the following countries: China, Japan, South Korea, ...
(Date:11/23/2014)... 23, 2014 Pro Ace Care, a renowned ... will now be providing an 8 year warranty on its ... tank installations went up due to the impending winter season, ... customers of the premium service that the company provides. As ... warranty on John Wood and Bradford hot water tanks. ...
(Date:11/23/2014)... 21, 2014 (HealthDay News) -- Close friends have more ... group does, a new study says. "We,ve ... have an influence on individual alcohol use, but there ... peer group and the friend group,s influence on those ... School of Public Health, said in a university news ...
(Date:11/23/2014)... 2014 Locks-Magnetic.com, a notable magnetic locks ... all the new products are available at low rates ... is proud of the new emergency doors. The emergency ... customers can choose from several colors. All of the ... emergency door release is not as easy as many ...
Breaking Medicine News(10 mins):Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Close Friends May Be Key to Teens' Drinking 2
... Institute of Health received over $100,000 from drug companies in ... to reports in a newspaper on Sunday. ,The actions ... year during an internal review, which concluded that he was ... according to reports from the Los Angeles Times. ,The ...
People who have a low response to alcohol or the so called ability to...
... gamblers have strong addiction to it.,"I'd say that there is ... I get from gambling," said one addict//. ,There ... thereby, creating more attraction for those with gambling problems. According ... the number of addicts. ,"It's related to other ...
... scientists have developed a new generation of antibiotics ... this approach bacteria has been rendered benign rather killed. ... bacteria in the light of several antibiotics losing their ... ,Tests have shown that these compounds actively blocked ...
... 10, sent a warning against dengue fever in the midst ... capital//. ,From this year’s January 1 to ... been reported, said the department. ,In order ... collaboration with the local officials of the affected areas, according ...
... A new survey has revealed that extreme and prolonged stress could ... could lead to grave health problems, a research has revealed.// ... sleep is a top worry for many, along with the rigors ... concerned with the bad effects of smoking or drinking, not even ...
Cached Medicine News:Health News:Medical researcher Accused of 'serious misconduct' 2Health News:Compulsive Gambling – a psychiatric disorde 2Health News:Latest Weapon in Battle against Drug-Resistant Bacteria 2Health News:‘Search and Destroy’ operation against dengue mosquitoes in Philippin 2
... 1/3 hp. 0-8 scfm/0-29.8 in.hg.@sea level. Incredibly ... to 4 collection canister systems at one ... changes during the procedure. Standard canister set-up ... filters not included). UL, c-UL and CE ...
... is a new term being used today to describe ... liquid fill that may have been used in silicone ... science, this is not new technology cohesive is ... the sticking together nature of the gel. All of ...
This Implant enhances and restores the nasal contour, The large selection of sizes with a variety of flares and lengths allows for more individualized results...
... designed to enhance the chin contour, this chin ... a high-profile central chin projection. Symmetrical Chin ... this implant provides a high central projection, as ... Cleft Chin Implants - Designed with a unique ...
Medicine Products: